Abbott teams with Google Health on AI-powered health insights app

MedTech Abbott teams with Google Health on AI-powered health insights app By Ben Adams Aug 11, 2026 9:00am Abbott Google Wearables Devices Two giants of their respective fields, Abbott and Google, are joining forces for a first-of-its-kind team-up that aims to build out a digital picture of people’s health. The partnership will wed Abbott’s Lingo consumer glucose wearable with Google Health’s AI technology to generate “personalized metabolic insights” via the Google Health app. By tapping these data and technologies through the Google Health app, “Lingo users will be able to view glucose trends alongside other health and wellness metrics in a unified experience, helping them better understand how daily behaviors influence their overall well-being,” the pair said in an Aug.

11 statement. Google's Health Coach can then use these data to provide personalized recommendations aimed at helping users develop healthier habits around nutrition, activity, sleep and recovery. Lingo has been on the market since 2024 as an over-the-counter consumer biowearable and continuous glucose monitoring system intended for people 18 and older who are not using insulin.

Related Over-the-counter CGM market grows, with Abbott’s Lingo debut The idea is for consumers to track their glucose levels during exercise or throughout their daily lives and make dietary choices based on the numbers. Google Health has been using its AI technology for similar health-focused applications, but the addition of Lingo could broaden its reach. As part of the pact, the pair said they will also undertake one of the largest real-world metabolic health studies.

The study will integrate continuous glucose, wearable, laboratory and survey data to examine connections between activity, sleep, well-being and metabolic health, with the goal of informing more personalized health guidance. There will also be an eye on identifying signs of prediabetes, a condition in which blood glucose levels are elevated but have not reached the threshold for diabetes. Earlier awareness could give people an opportunity to make lifestyle changes aimed at reducing their risk of developing Type 2 diabetes.

“The biggest challenge in healthcare isn't treating disease—it's helping people stay healthier longer,” Olivier Ropars, divisional vice president of Abbott’s Lingo business, said in the release. “Abbott's leadership in biowearables and Google's expertise in AI and consumer technology create a powerful opportunity to make personalized insights available at unprecedented scale. Additionally, we are advancing metabolic health research through one of the largest real-world studies of its kind, generating new insights into the relationship between glucose and everyday behaviors.

That research will help shape future AI-powered guidance and metabolic health innovation.” Abbott Google Wearables Devices MedTech